Showing 1 - 7 results of 7 for search 'Kate Rittenhouse-Olson', query time: 0.03s Refine Results
  1. 1
    Glycodendrimers: versatile tools for nanotechnology

    Glycodendrimers: versatile tools for nanotechnology by René Roy, Tze Chieh Shiao, Kate Rittenhouse-Olson

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy.

    Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy. by Leike Xie, Zhe Sun, Zhongkui Hong, Nicola J Brown, Olga V Glinskii, Kate Rittenhouse-Olson, Gerald A Meininger, Vladislav V Glinsky

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Inhibition of Spontaneous Breast Cancer Metastasis by Anti—Thomsen-Friedenreich Antigen Monoclonal Antibody JAA-F11

    Inhibition of Spontaneous Breast Cancer Metastasis by Anti—Thomsen-Friedenreich Antigen Monoclonal Antibody JAA-F11 by Jamie Heimburg, Jun Yan, Susan Morey, Olga V. Glinskii, Virginia H. Huxley, Linda Wild, Robert Klick, Rene Roy, Vladislav V. Glinsky, Kate Rittenhouse-Olson

    Published 2006-11-01
    Get full text
    Article
  4. 4
    Development, Characterization, and Immunotherapeutic Use of Peptide Mimics of the Thomsen-Friedenreich Carbohydrate Antigen

    Development, Characterization, and Immunotherapeutic Use of Peptide Mimics of the Thomsen-Friedenreich Carbohydrate Antigen by Jamie Heimburg-Molinaro, Adel Almogren, Susan Morey, Olga V. Glinskii, Rene Roy, Gregory E. Wilding, Richard P. Cheng, Vladislav V. Glinsky, Kate Rittenhouse-Olson

    Published 2009-08-01
    Get full text
    Article
  5. 5
    Computational screening of the human TF-glycome provides a structural definition for the specificity of anti-tumor antibody JAA-F11.

    Computational screening of the human TF-glycome provides a structural definition for the specificity of anti-tumor antibody JAA-F11. by Matthew B Tessier, Oliver C Grant, Jamie Heimburg-Molinaro, David Smith, Snehal Jadey, Andrew M Gulick, John Glushka, Susan L Deutscher, Kate Rittenhouse-Olson, Robert J Woods

    Published 2013-01-01
    Get full text
    Article
  6. 6
    Preclinical Analysis of JAA-F11, a Specific Anti–Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging

    Preclinical Analysis of JAA-F11, a Specific Anti–Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging by Loukia G. Karacosta, John C. Fisk, Joseph Jessee, Swetha Tati, Bradley Turner, Diala Ghazal, Rachel Ludwig, Holly Johnson, Julia Adams, Munawwar Sajjad, Steven Koury, Rene Roy, James R. Olson, Kate Rittenhouse-Olson

    Published 2018-04-01
    Get full text
    Article
  7. 7
    Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]

    Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733] by Swetha Tati, John C. Fisk, Julia Abdullah, Loukia Karacosta, Taylor Chrisikos, Padraic Philbin, Susan Morey, Diala Ghazal, Fatma Zalzala, Joseph Jessee, Sally Quataert, Stephen Koury, David Moreno, Jing Ying Eng, Vladislav V. Glinsky, Olga V. Glinskii, Muctarr Sesay, Anthony W. Gebhard, Karamverr Birthare, James R. Olson, Kate Rittenhouse-Olson

    Published 2018-01-01
    Get full text
    Article

Search Tools: